Your browser doesn't support javascript.
loading
Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid.
Pfaar, O; Hohlfeld, J M; Al-Kadah, B; Hauswald, B; Homey, B; Hunzelmann, N; Schliemann, S; Velling, P; Worm, M; Klimek, L.
Afiliação
  • Pfaar O; Department of Otorhinolaryngology, Head and Neck Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Hohlfeld JM; Center for Rhinology and Allergology Wiesbaden, Wiesbaden, Germany.
  • Al-Kadah B; Fraunhofer Institute for Toxicology and Experimental Medicine ITEM; Member of the German Center for Lung Research, Hannover, Germany.
  • Hauswald B; Hannover Medical School, Hannover, Germany.
  • Homey B; Department of Otorhinolaryngology, Saarland University Medical Center, Homburg/Saar, Germany.
  • Hunzelmann N; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
  • Schliemann S; Department of Dermatology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Velling P; Department of Dermatology, University Hospital of Cologne, Cologne, Germany.
  • Worm M; Department of Dermatology, Jena University Hospital, Jena, Germany.
  • Klimek L; Medical Care Centre of Evangelical Chest Clinic Berlin, Berlin, Germany.
Clin Exp Allergy ; 47(11): 1445-1455, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28696503
BACKGROUND: Subcutaneous allergen immunotherapy with grass pollen allergoids has been proven to be effective and safe in the treatment of patients with allergic rhinoconjunctivitis. Based on the extensive cross-reactivity among Pooideae species, it has been suggested that grass pollen extracts could be prepared from a single species, rather than from a multiple species mixture. OBJECTIVE: To find the optimal dose of a Phleum pratense (P. pratense) allergoid preparation and compare its efficacy and safety to a 6-grass pollen allergoid preparation. METHODS: In this double-blind, placebo-controlled study (EudraCT: 2011-000674-58), three doses of P. pratense allergoid (1800 therapeutic units (TU), standard-dose 6000 TU and 18 000 TU) were compared with placebo and the marketed 6-grass pollen allergoid (6000 TU). In a pre-seasonal dosing regimen, 102 patients were randomized to five treatment groups and received nine subcutaneous injections. The primary efficacy endpoint was the change in weal size (late-phase reaction [LPR]) in response to the intracutaneous testing (ICT) before and after treatment, comparing the active allergoids to placebo. Secondary outcomes were the change in Total Nasal Symptom Score (TNSS) assessed in the allergen exposure chamber (AEC), the changes in P. pratense-serum-specific IgG4 and the incidence of adverse events (AEs). RESULTS: All three doses of the P. pratense and the 6-grass pollen allergoid preparations were significantly superior to placebo for the primary outcome, whereas there were no significant differences in the change in TNSS. Compared to the standard-dose, the high-dose of P. pratense did not produce any additional significant benefit, but showed a slight increase in AEs. Yet this increase in AEs was lower than for the 6-grass pollen preparation. CONCLUSIONS & CLINICAL RELEVANCE: The standard-dose of the new P. pratense allergoid was comparable to the marketed 6-grass pollen preparation at equal dose for the parameters measured.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pólen / Alérgenos / Extratos Vegetais / Rinite Alérgica Sazonal / Phleum / Relação Dose-Resposta Imunológica Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Clin Exp Allergy Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pólen / Alérgenos / Extratos Vegetais / Rinite Alérgica Sazonal / Phleum / Relação Dose-Resposta Imunológica Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Clin Exp Allergy Ano de publicação: 2017 Tipo de documento: Article